Viracta Therapeutics Inc (VIRX)
0.47
-0.01
(-2.29%)
USD |
NASDAQ |
Jul 05, 16:00
0.47
0.00 (0.00%)
After-Hours: 19:15
Viracta Therapeutics Free Cash Flow: -36.40M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -36.40M |
| December 31, 2023 | -40.03M |
| September 30, 2023 | -37.91M |
| June 30, 2023 | -34.58M |
| March 31, 2023 | -35.48M |
| December 31, 2022 | -35.50M |
| September 30, 2022 | -34.83M |
| Date | Value |
|---|---|
| June 30, 2022 | -39.50M |
| March 31, 2022 | -37.02M |
| December 31, 2021 | -23.10M |
| September 30, 2021 | -20.41M |
| June 30, 2021 | -12.85M |
| March 31, 2021 | -9.90M |
| December 31, 2020 | -16.05M |
Free Cash Flow Range, Past 5 Years
-40.03M
Minimum
Dec 2023
-9.90M
Maximum
Mar 2021
-29.54M
Average
-35.15M
Median
Free Cash Flow Benchmarks
| XOMA Corp | -18.20M |
| Marinus Pharmaceuticals Inc | -113.98M |
| Cartesian Therapeutics Inc | -58.99M |
| Adial Pharmaceuticals Inc | -6.134M |
| NovaBay Pharmaceuticals Inc | -4.524M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.849M |
| Cash from Investing (Quarterly) | 14.19M |
| Cash from Financing (Quarterly) | -6.598M |
| Free Cash Flow Per Share (Quarterly) | -0.1996 |
| Free Cash Flow Yield | -199.4% |